Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 42.6% in January

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 55,500 shares, a decrease of 42.6% from the December 31st total of 96,700 shares. Approximately 1.3% of the shares of the stock are sold short. Based on an average daily volume of 946,700 shares, the short-interest ratio is presently 0.1 days.

Venus Concept Price Performance

NASDAQ VERO traded down $0.01 on Thursday, reaching $0.35. 127,369 shares of the stock traded hands, compared to its average volume of 277,430. Venus Concept has a 12 month low of $0.28 and a 12 month high of $2.22. The company has a market cap of $2.56 million, a price-to-earnings ratio of -0.04 and a beta of 0.47. The firm’s fifty day simple moving average is $0.35 and its 200 day simple moving average is $0.47. The company has a quick ratio of 1.18, a current ratio of 1.86 and a debt-to-equity ratio of 2.83.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.